-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $240.00/Share From $300.00 by Morgan Stanley

Dow Jones·10/30/2026 17:48:00

Please log in to view news